Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sanofi crawled date : 2021 - 05 - 17 save search
Five ways to improve your business with Business Services
Published: 2021-05-17 (Crawled : 19:00) - modeln.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.22%
H: 0.1%
C: -0.26%
Positive Phase II Results Show There's Still Hope for the Sanofi/GSK COVID-19 Vaccine
Published: 2021-05-17 (Crawled : 15:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.11%
H: 0.87%
C: -0.01%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
covid positive results vaccine covid-19
Positive Phase II Results Show There's Still Hope for the Sanofi/GSK COVID-19...
Published: 2021-05-17 (Crawled : 15:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.11%
H: 0.87%
C: -0.01%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
covid positive results covid-19
Phase 3 Data Presented at ATS 2021 Show REGEN-COV™ (casirivimab with imdevimab) Reduced Risk of Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients
Published: 2021-05-17 (Crawled : 14:15) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
|
| O: -0.03%
H: 1.84%
C: 1.41%
covid risk casirivimab phase 3
Escient Pharmaceuticals Appoints Christian Weyer, M.D., M.A.S., as President and Chief Medical Officer
Published: 2021-05-17 (Crawled : 14:15) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
eye
Pivotal data at ATS 2021 show Dupixent® (dupilumab) significantly reduced asthma attacks and improved lung function in children
Published: 2021-05-17 (Crawled : 14:15) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
|
| O: -0.03%
H: 1.84%
C: 1.41%
children dupixent
ESPERION Appoints Sheldon Koenig as President and CEO
Published: 2021-05-17 (Crawled : 13:15) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
ESPR | $2.08 8.9% 8.17% 4.9M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: -8.1%
ceo leo
AavantiBio Rounds Out Leadership Team with Appointment of Jessie Hanrahan, Ph.D. as Chief Regulatory Officer
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
BSX | $68.99 1.43% 0.19% 9.1M
|
Health Technology
|
| O: -0.12%
H: 0.77%
C: 0.53%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
BLUE | $0.9739 2.13% 2.08% 4.8M
|
Health Technology
|
| O: -1.06%
H: 2.33%
C: -0.3%
IBIO | $1.9 6.74% 0.0% 150K
|
Health Technology
|
| O: -7.48%
H: 6.44%
C: 0.0%
Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups in Phase 2 trial
Published: 2021-05-17 (Crawled : 06:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.11%
H: 0.87%
C: -0.01%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
covid phase 2 vaccine trial response
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.